Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash Flows from Operating Activities:
Net loss	$ (1,120,789)	$ (832,400)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	29,074	21,028
Net realized losses (gains) on the sale of securities	(40,653)	849
Amortization of investment securities, net	12,406	12,160
Deferred acquisition costs capitalized	(182,537)	(105,045)
Deferred acquisition costs amortized	128,540	83,791
Interest credited on deposit type contracts	49,395	20,333
(Increase) decrease in operating assets:
Investment income due and accrued	3,097	(10,243)
Reinsurance related assets	(51,893)	(12,443)
Pre-paid expenses	96,207	(118,034)
Other assets	(4,854)	5,818
Increase (decrease) in operating liabilities:
Policyowner benefit reserves	1,497,064	810,785
Advance premiums	41,297	29,220
Other liabilities	73,434	378,928
Accounts payable and accrued expenses	(16,609)	(13,669)
Net cash provided by operating activities	513,179	271,078
Cash Flows from Investing Activities:
Purchase of fixed income investments	(2,624,560)	(1,960,485)
Purchase of equity investments	(1,210,646)	(1,497,703)
Proceeds from fixed income sales and repayments	573,590	314,322
Proceeds from equity sales and repayments	190,583	104,137
Purchase of property, equipment and software		(24,524)
Net cash (used in) investing activities	(3,071,033)	(3,064,253)
Cash Flows from Financing Activities:
Receipts on deposit-type contracts	1,485,628	670,750
Withdrawals on deposit-type contracts	(170,906)	(34,278)
Proceeds received from exercise of warrants, net of costs of issuance	1,783,835	3,528,835
Net cash provided by financing activities	3,098,557	4,165,307
Net increase in cash and cash equivalents	540,703	1,372,132
Cash and Cash Equivalents:
Beginning	2,466,526	575,005
Ending	$ 3,007,229	$ 1,947,137